MedTrace Logo

Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy

NCT05229874 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2023-10-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of carbon nanoparticle suspension injection and indocyanine green tracer-guided lymph node dissection during gastrectomy in patients with gastric cancer

Conditions

Interventions

DRUG

carbon nanoparticles

Endoscopic injection

DRUG

Indocyanine green

Endoscopic injection

Sponsors & Collaborators

  • Hebei Medical University

    lead OTHER

Principal Investigators

  • Qun Zhao · Departments of Third Surgery, Fourth Hospital of Hebei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2023-03-09
Completion
2025-01-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05229874 on ClinicalTrials.gov